Zoonotic diseases are infections that spread between animals and humans, caused by bacteria, viruses, parasites, or fungi. Examples include rabies, avian influenza, brucellosis, and coronaviruses such as SARS, MERS, and COVID-19. These diseases account for the majority of emerging infectious threats worldwide, often linked to wildlife trade, intensive farming, and environmental changes. Preventing zoonoses requires strong surveillance systems, vaccination programs, safe food practices, and the adoption of the One Health approach, integrating human, animal, and environmental health efforts.
Market Analysis: In 2025, the global zoonotic diseases market—which includes diagnostics, vaccines, therapeutics, and surveillance systems—is valued at about USD 7.9 billion. With increasing zoonotic outbreaks and global focus on pandemic preparedness, the market is projected to reach USD 13.6 billion by 2030, growing at a CAGR of 11.0%. North America and Europe lead in advanced research and vaccine development, while Asia-Pacific and Africa represent the fastest-growing regions due to high zoonotic disease prevalence and expanding public health investments. Rising collaborations between veterinary and human health sectors are expected to fuel long-term market growth.
